SC 13G | 2016-02-10 | Apex Capital Management | ENANTA PHARMACEUTICALS INC | 1,234,383 | 5.0% | EDGAR |
SC 13G/A | 2016-02-03 | Dworsky Alan J | ENANTA PHARMACEUTICALS INC | 1,414,985 | 7.5% | EDGAR |
SC 13G | 2016-01-28 | BlackRock Inc. | ENANTA PHARMACEUTICALS INC | 1,677,254 | 8.9% | EDGAR |
SC 13G/A | 2016-01-25 | EAGLE ASSET MANAGEMENT INC | ENANTA PHARMACEUTICALS INC | 1,095,425 | 5.8% | EDGAR |
SC 13G/A | 2015-05-11 | FMR LLC | ENANTA PHARMACEUTICALS INC | 953,388 | 5.1% | EDGAR |
SC 13G/A | 2015-02-17 | RA CAPITAL MANAGEMENT, LLC | ENANTA PHARMACEUTICALS INC | 0 | 0.0% | EDGAR |
SC 13G | 2015-02-17 | Consonance Capital Management LP | ENANTA PHARMACEUTICALS INC | 1,696,147 | 9.1% | EDGAR |
SC 13G/A | 2015-02-13 | FMR LLC | ENANTA PHARMACEUTICALS INC | 2,135,263 | 11.5% | EDGAR |
SC 13G/A | 2015-02-10 | Dworsky Alan J | ENANTA PHARMACEUTICALS INC | 1,114,985 | 6.0% | EDGAR |
SC 13G | 2015-01-07 | EAGLE ASSET MANAGEMENT INC | ENANTA PHARMACEUTICALS INC | 1,109,644 | 6.0% | EDGAR |
SC 13G | 2014-09-18 | Dworsky Alan J | ENANTA PHARMACEUTICALS INC | 998,156 | 5.4% | EDGAR |
SC 13G | 2014-04-01 | RA CAPITAL MANAGEMENT, LLC | ENANTA PHARMACEUTICALS INC | 1,541,078 | 8.0% | EDGAR |
SC 13G | 2014-02-14 | FMR LLC | ENANTA PHARMACEUTICALS INC | 1,298,476 | 7.2% | EDGAR |
SC 13G | 2014-02-14 | TVM V LIFE SCIENCE VENTURES GMBH & CO KG | ENANTA PHARMACEUTICALS INC | 2,532,119 | 14.1% | EDGAR |
SC 13G/A | 2014-02-13 | HBM Healthcare Investments (Cayman) Ltd. | ENANTA PHARMACEUTICALS INC | 868,088 | 4.8% | EDGAR |
SC 13G | 2014-02-13 | mRNA - Holdings LLC | ENANTA PHARMACEUTICALS INC | 15,634 | 0.1% | EDGAR |
SC 13G/A | 2014-02-10 | FMR LLC | ENANTA PHARMACEUTICALS INC | 2,077,878 | 11.6% | EDGAR |
SC 13G | 2014-02-07 | AbbVie Inc. | ENANTA PHARMACEUTICALS INC | 1,072,103 | 6.0% | EDGAR |
SC 13G | 2014-01-29 | SHIONOGI & CO LTD | ENANTA PHARMACEUTICALS INC | 1,599,760 | 8.9% | EDGAR |
SC 13G | 2013-04-03 | HBM Healthcare Investments (Cayman) Ltd. | ENANTA PHARMACEUTICALS INC | 1,463,976 | 8.7% | EDGAR |